Novo CEO pressed by Senate to chop prices of weight problems, diabetic issues medicines CEO Lars Fruergaard Jørgensen told lawmakers the business would take into consideration new talks with insurers in regards to the record rates of Wegovy and copyright whenever they pledge to maintain the medicines on their formularies. https://josueogwmc.gynoblog.com/30098259/the-2-minute-rule-for-healthcare-news